Search

Filters

Clear Filters
3:00 PM - 4:00 PM ET

2077 - Definitive Proton Beam Therapy for Oligometastatic Disease from Colorectal Cancer: A Single-Institution Retrospective Study Assessing the ESTRO-EORTC Classification
Speaker: Goto, Masaaki, MD, PhD - University of Tsukuba, Tsukuba City 305-8575, Ibaraki
3:00 PM - 4:00 PM ET

2078 - Comparative Outcomes of Preoperative vs. Postoperative Stereotactic Radiosurgery for Resected Brain Metastases: A Meta-Analysis (COPPER-BrM)
Speaker: Gouveia, Andre, MD, MBA - McMaster University, Hamilton, On
3:00 PM - 4:00 PM ET

2079 - Assessment of IDH-Mutated Glioma Treatment Response to Long-Term Targeted Therapy by Longitudinal Tumor Volume Measurements
Speaker: Greenlund, Lindsey, MD - Johns Hopkins Hospital, Baltimore, MD
11:35 AM - 11:45 AM ET

208 - Bridging Radiotherapy Reduces Systemic Inflammation Prior to CAR T-Cell Therapy for B-Cell Lymphomas
Speaker: Imber, Brandon, MD, MS - Memorial Sloan Kettering Cancer Center, New York, NY
3:00 PM - 4:00 PM ET

2080 - Stereotactic Radiosurgery Provides Tumor Control for Cranial Non-Vestibular Schwannomas
Speaker: Gribble, Michael, MD - UCSF Comprehensive Cancer Center, San Francisco, CA
3:00 PM - 4:00 PM ET

2081 - Prospective Evaluation of Early Cardiotoxicity in Patients Undergoing Photon or Proton Radiation Therapy for Locally-Advanced Distal Esophageal Cancer
Speaker: Gupta, Nikita, BS - Georgetown University School of Medicine, Washington, DC
3:00 PM - 4:00 PM ET

2082 - Real-World Data: Postoperative Concurrent Chemorradiation for Resected Locally Advanced Gastric Cancer - Treatment Patterns and Risk Stratification
Speaker: Gutierrez Torres, Salvador, MD - Instituto Nacional de Cancerologia, Mexico City, CIUDAD DE MÉXICO
3:00 PM - 4:00 PM ET

2083 - Modeling Pre-Operative Spine Stereotactic Body Radiation Therapy (SBRT) for Treatment of Metastatic Spinal Disease Requiring Spinal Decompression Surgery
Speaker: Hall, Julia - Loyola University Chicago, Stritch School of Medicine, Maywood, IL
3:00 PM - 4:00 PM ET

2084 - Clinical Context Improves Interpretation of ¹8F-Fluciclovine PET and Perfusion MRI for Distinguishing Radiation Necrosis from Tumor Recurrence Following Radiation Therapy for Brain Metastases
Speaker: Harrell, Marshall, MD - The Ohio State University James Cancer Hospital, Columbus, OH
3:00 PM - 4:00 PM ET

2085 - ¹8F Fluciclovine PET In Postoperative Target Delineation and Recurrence Detection In Resected Brain Metastasis: Pre-Planned Analysis of a Prospective Trial
Speaker: NaniparuthayilHassan, Hanan, MD, MBBS - Bangalore Medical College and Research Institute, Bengaluru, Karnataka
3:00 PM - 4:00 PM ET

2086 - Role of SBRT in the Management of Metastatic Colorectal Cancer: Oncologic Outcomes and Prognostic Factors from a Single-Institution Experience
Speaker: Hassan, Khaled, MD, MBBS - Kasr Al-Ainy Center of Radiation Oncology and Nuclear Medicine, Cairo
3:00 PM - 4:00 PM ET

2087 - Integration of MRI Radiomics and Host Inflammatory and Nutritional Factors for Predicting Pathological Complete Response after Chemoradiotherapy in Esophageal Squamous Cell Carcinoma
Speaker: Hayano, Koichi, MD - Department of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba